E.I. Du Pont De Nemours and Company (DD) 55.38 $DD Woman

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
E.I. Du Pont De Nemours and Company (DD) 55.38 $DD

Woman awarded $1.6 million over DuPont chemical in water
AP - 57 mins ago
COLUMBUS, Ohio (AP) — An Ohio woman who says she got cancer after drinking water contaminated by a chemical from a DuPont plant near Parkersburg, West Virginia, has been awarded $1.6 million.
DD: 55.38 (+0.17)

Stock Market News for October 07, 2015
Zacks Equity Research - Zacks Investment Research - Wed Oct 07, 9:10AM CDT
Benchmarks finished mixed on Tuesday after a selloff in healthcare stocks offset gains in energy and materials shares
KMI: 32.14 (+0.36), BIIB: 279.24 (+3.25), MON: 88.06 (-0.02), AMGN: 148.05 (+6.83), XOM: 79.20 (+1.31), COP: 55.27 (+0.13), SLB: 75.35 (+1.41), CELG: 116.98 (+4.79), LYB: 95.59 (+1.96), GILD: 100.27 (+2.73), DD: 55.38 (+0.17), CVX: 88.12 (+1.13), DOW: 47.49 (+0.41), REGN: 485.76 (+25.94), ECL: 118.27 (+1.08)

Jim Cramer's Top Takeaways: Microsoft, Intel, Premier, PepsiCo, DuPont
at The Street - Wed Oct 07, 5:00AM CDT
Microsoft and Intel are doing better than before while DuPont's CEO found out what happens when you fight Nelson Peltz, Cramer says.
DD: 55.38 (+0.17), INTC: 32.31 (+0.57), MSFT: 46.80 (+0.05), PINC: 36.36 (+1.36), PEP: 98.52 (+1.45)


Asian shares mostly higher, Japan muted on BOJ decision
By YURI KAGEYAMA - AP - Tue Oct 06, 10:23PM CDT
TOKYO (AP) — Asian stock markets were mostly higher Wednesday, taking in stride the IMF's lower global growth forecast, while Japan traded cautiously as its central bank left monetary policy unchanged.
XOM: 79.20 (+1.31), COP: 55.27 (+0.13), DD: 55.38 (+0.17), CVX: 88.12 (+1.13)

Jim Cramer's 'Mad Money' Recap: What Ails the Market? Drug Stocks
at The Street - Tue Oct 06, 7:04PM CDT
The drug stocks are competing with the oil patch for the prize of the worst sector in the entire market, Cramer says.
TDOC: 16.23 (-0.41), FEYE: 32.12 (+0.94), BX: 34.70 (+0.90), SWKS: 83.61 (+2.90), CYBR: 52.86 (+0.66), STX: 47.29 (+1.09), CNP: 18.57 (+0.08), INTC: 32.31 (+0.57), PANW: 174.98 (+0.86), PEP: 98.52 (+1.45), RIG: 16.34 (+0.59), CMG: 720.16 (+6.91), CVS: 101.01 (+1.19), DD: 55.38 (+0.17), LINE: 3.38 (+0.19), MSFT: 46.80 (+0.05), PINC: 36.36 (+1.36), CSCO: 27.54 (+0.31)

DuPont Shares Bolt Higher as CEO Steps Down
Zacks Equity Research - Zacks Investment Research - Tue Oct 06, 3:50PM CDT
Shares of DuPont (DD) ripped higher after it announced that its CEO Ellen Kullman will retire next week.
TYC: 35.58 (+0.41), MDLZ: 44.33 (+0.43), CC: 7.87 (-0.34), DD: 55.38 (+0.17)

DuPont and Illumina are big market movers
AP - Tue Oct 06, 3:44PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Tuesday on the New York Stock Exchange and the Nasdaq Stock Market:
GE: 27.77 (+0.48), SWKS: 83.61 (+2.90), ILMN: 145.94 (+0.13), TCS: 12.04 (-0.63), CELG: 116.98 (+4.79), PEP: 98.52 (+1.45), AA: 10.94 (-0.04), NWL: 41.66 (+0.72), ONCE: 44.81 (-5.59), DE: 78.89 (+0.45), DD: 55.38 (+0.17), BP: 35.71 (+1.40), TWTR: 29.83 (+2.21), GIS: 55.72 (+0.02)

Stocks Close Mixed as Biotech Slumps, Energy Jumps
at The Street - Tue Oct 06, 3:38PM CDT
It's a very different day of trading for the investor favoring energy stocks compared to those hedging their bets on biotech.
BIIB: 279.24 (+3.25), SWKS: 83.61 (+2.90), HAL: 39.86 (+0.82), ILMN: 145.94 (+0.13), XOM: 79.20 (+1.31), IBB: 307.79 (+5.88), COP: 55.27 (+0.13), PMCS: 10.18 (-0.06), TCS: 12.04 (-0.63), LLY: 83.99 (-0.18), BMY: 60.55 (+0.67), ENS: 64.70 (+0.84), PEP: 98.52 (+1.45), AA: 10.94 (-0.04), DD: 55.38 (+0.17), TEVA: 58.55 (+0.58), CVX: 88.12 (+1.13), PTR: 79.48 (+3.96), JCI: 43.86 (+0.80), XLE: 68.09 (+0.85)

DuPont Still has Upside; Investors Seek Value Over Growth
at The Street - Tue Oct 06, 2:44PM CDT
The CNBC 'Fast Money' traders say DuPont still has upside despite Tuesday's 10% rally, while PepsiCo, McDonald's and Yum! Brands could also continue to rally.
SPY: 199.41 (+1.62), DIA: 168.95 (+1.26), MCD: 101.77 (-0.13), DD: 55.38 (+0.17), IBB: 307.79 (+5.88), BWLD: 194.16 (+3.32), PEP: 98.52 (+1.45), TXRH: 38.37 (+0.17), YUM: 67.71 (-15.71), XLE: 68.09 (+0.85)

Dow Edges Up as Oil Closes at Five-Week High
at The Street - Tue Oct 06, 2:16PM CDT
Stocks are mixed on Tuesday afternoon as energy pushes the Dow Jones Industrial Average higher while a biotech selloff weighs on the Nasdaq.
BUD: 110.96 (+1.36), BIIB: 279.24 (+3.25), SWKS: 83.61 (+2.90), HAL: 39.86 (+0.82), TAP: 82.21 (+1.22), ILMN: 145.94 (+0.13), IBB: 307.79 (+5.88), XOM: 79.20 (+1.31), COP: 55.27 (+0.13), PMCS: 10.18 (-0.06), TCS: 12.04 (-0.63), LLY: 83.99 (-0.18), BMY: 60.55 (+0.67), PEP: 98.52 (+1.45), AA: 10.94 (-0.04), DD: 55.38 (+0.17), TEVA: 58.55 (+0.58), CVX: 88.12 (+1.13), AAPL: 110.78 (-0.53), PTR: 79.48 (+3.96), XLE: 68.09 (+0.85)

DuPont shares rise as CEO announces retirement
AP - Tue Oct 06, 12:34PM CDT
NEW YORK (AP) — Shares of DuPont gained ground Tuesday following the announcement that CEO and Chairwoman Ella Kullman will retire at the end of next week.
CC: 7.87 (-0.34), DD: 55.38 (+0.17)

Why E.I. du Pont de Nemours and Co's Shares Jumped 11% Today
Travis Hoium, The Motley Fool - Motley Fool - Tue Oct 06, 11:41AM CDT
What: Shares of E.I. du Pont de Nemours and Co. , or DuPont, as it's commonly known, have jumped 11% today after CEO and Chairwoman Ella Kullman announced her retirement. So what: Kullman and DuPont have been in a battle with Nelson Peltz and...
DD: 55.38 (+0.17)

Jim Cramer -- Peltz Will Be Great for GE, Amazon Can't Hurt Apple TV
at The Street - Tue Oct 06, 11:19AM CDT
On Tuesday, Jim Cramer discussed what's ahead for the stock market, why you should own General Electric, and why he's a fan of Columbia Sportswear.
BIIB: 279.24 (+3.25), AMZN: 541.94 (+4.46), GE: 27.77 (+0.48), VFC: 69.67 (-0.08), COLM: 57.77 (+0.57), XOM: 79.20 (+1.31), LULU: 54.00 (+2.26), PEP: 98.52 (+1.45), CELG: 116.98 (+4.79), JNJ: 94.98 (+1.56), AA: 10.94 (-0.04), GILD: 100.27 (+2.73), DD: 55.38 (+0.17), AAPL: 110.78 (-0.53)

DuPont and PepsiCo: It's All About the Numbers
at The Street - Tue Oct 06, 10:22AM CDT
Differing results and dealings with Nelson Peltz produce a CEO winner and loser.
TYC: 35.58 (+0.41), CC: 7.87 (-0.34), DD: 55.38 (+0.17), PEP: 98.52 (+1.45)

Could Nelson Peltz Still Split Up DuPont?
at The Street - Tue Oct 06, 10:00AM CDT
DuPont CEO Ellen Kullman’s interim replacement Edward Breen is likely to intrigue activist investors like Nelson Peltz, who has tried and so far failed to break up DuPont.
TYC: 35.58 (+0.41), DD: 55.38 (+0.17)

Stocks Move Back Into Red as Biotech Sells Off Again
at The Street - Tue Oct 06, 9:36AM CDT
Stocks move back into the red by mid-morning Tuesday as the biotech sector suffers another selloff.
BUD: 110.96 (+1.36), BIIB: 279.24 (+3.25), SWKS: 83.61 (+2.90), TAP: 82.21 (+1.22), IBB: 307.79 (+5.88), ILMN: 145.94 (+0.13), LLY: 83.99 (-0.18), TCS: 12.04 (-0.63), PMCS: 10.18 (-0.06), BMY: 60.55 (+0.67), PEP: 98.52 (+1.45), AA: 10.94 (-0.04), DD: 55.38 (+0.17), TEVA: 58.55 (+0.58), AAPL: 110.78 (-0.53)

DuPont CEO Ellen Kullman's Departure Is a Big Gain for Shareholders
at The Street - Tue Oct 06, 9:00AM CDT
Interim CEO Ed Breen has a proven record of success.
DD: 55.38 (+0.17)

DuPont (DD) Stock Gains After CEO Announces Departure, Jim Cramer's View
at The Street - Tue Oct 06, 8:54AM CDT
DuPont (DD) stock is rising after CEO Ellen Kullman announced she will leave the company next week.
DD: 55.38 (+0.17)

Something Wicked This Way Comes for Market
at The Street - Tue Oct 06, 8:30AM CDT
There are worrisome signs to this short-term buying spree.
IBM: 150.09 (+1.31), NDLS: 13.86 (+0.05), MCD: 101.77 (-0.13), DD: 55.38 (+0.17), PNR: 55.19 (+0.83), CAT: 70.38 (-0.44), TWTR: 29.83 (+2.21), YUM: 67.71 (-15.71)

DuPont CEO to Retire; Time to Buy?
at The Street - Tue Oct 06, 8:01AM CDT
With Kullman stepping down as CEO, will DuPont's stock be a good investment?
DD: 55.38 (+0.17)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Unicycive Faces Legal Heat Amid Stock Tumble

Updated Category News Views 22

Unicycive Therapeutics' Rough Ride In this wild market, sometimes even the most seasoned investors get blindsided. Unicycive Therapeutics (NASDAQ: UNC) shareholders are currently caught in a storm with their stock nose-diving by 39.1% on June 30, 2026. It's like being taken to the cleaners without the decency of a warning. Failed Expectations & FDA Blues Here's the...

Continue Reading
Savvy Moves: Avoiding Pitfalls When Buying Used Vans

Updated Category News Views 14

When you're eyeing a used work van, don't just kick the tires and jot down the mileage—there's a whole backyard BBQ checklist you need to chew through. Tony Collichio, the work van guru from Spencerport, lays it down for us, highlighting key questions to ask before pulling out the checkbook. And let me tell you, these aren’t your everyday 'how does it drive?' queries....

Continue Reading
Effective Youth Hockey Skills: Mastering the Basics

Updated Category News Views 35

Laying Down the Tracks: Essential Foundations in Hockey When it comes to developing youth hockey skills, there's no magic formula or flashy trick that'll make overnight stars out of young players. According to HelloNation's recent piece featuring hockey development expert Dave Maksymiu, it’s all about going back to basics. This seems to be the memo often missed by...

Continue Reading
Parents Nationwide Rally for Youth Online Safety Imperative

Updated Category News Views 35

Ringing the Alarm on Digital Dangers Like trying to herd cats on a wild day at the market, keeping teens safe online is a task as tricky as they come. And now, with over 20,000 parents joining forces, it seems there's a real demand out there for some much-needed consistency in online safeguards across all social media platforms. This isn't just about one platform or...

Continue Reading
FDA Nod for Subcutaneous SKYRIZI in Crohn's Disease

Updated Category News Views 48

AbbVie's Injection Makes Waves in Crohn's Treatment Here's a bit of medicine shake-up for you. AbbVie just snagged FDA approval for its subcutaneous SKYRIZI—specifically designed for adults battling moderately to severely active Crohn's disease. This news isn't just a blip on the radar; it's significant for patients and the healthcare landscape. We're talking about new...

Continue Reading
DCK Reveals Versatile Battery-Powered Garden Tools in 2026

Updated Category News Views 65

Battery-Powered Revolution in Louisville The treadmill of lawn care just took a high-tech spin with DCK Tools strutting their stuff at Equip Exposition 2026. Unrolled at the Kentucky Exposition Center, the event from October 21 to 23 was brimming with their battery-powered wares that aim to take the grunt out of yard work. Game-Changing Range of Garden Tools DCK's decked...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 0

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
DigitalXForce Booms with 514% Growth and Major Backing

Updated Category News Views 143

Massive Growth and Strategic Investment in DigitalXForce Now here’s a company that’s shaking things up—DigitalXForce. Right on the back of a staggering 514% growth, they’ve corralled a strategic investment from Arsenal Growth Equity. If you blink, you might miss just how fast they’re sprinting through the tech landscape. Institutional Support Backing the...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 0

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 40

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Neurocrine Biosciences Unveils Potential of CRENESSITY™ for CAH

Updated Category News Views 379

Overview of CRENESSITY™ Approval Neurocrine Biosciences, Inc. announced a significant breakthrough with the FDA's approval of CRENESSITY™ (crinecerfont), marking the first new treatment for classic congenital adrenal hyperplasia (CAH) in nearly seven decades. This innovative therapy represents a profound shift in the management of this serious genetic condition that...

Continue Reading
Solidion Tech Hits Pause on S-1 Amid Market Forces

Updated Category News Views 15

Solidion's Strategic Withdrawal: Timing or Tactical Move? Solidion Technology, for all intents and purposes, just took a step back. Now, before we wave our hands in panic, let's stew over why the withdrawal of their S-1 registration might actually be more of a tactical retreat than a sign of sinking ship. They're pulling the plug on this specific filing—not because...

Continue Reading
Exploring the Future of the Couriers Market and AI's Role

Updated Category News Views 461

The Promising Growth of the Global Couriers Market The couriers market is on the brink of transformation, with expected growth of USD 115.9 billion from 2024 to 2028. This remarkable expansion is being driven primarily by advancements in technology and the integration of artificial intelligence (AI) in various logistics processes. During this period, the market is...

Continue Reading
Survey Reveals Growing Advisor Interest in Private Market Allocations

Updated Category News Views 213

Insights Into Private Market Allocations by Advisors A recent survey highlights a transformative trend among investment advisors regarding their allocation strategies. According to the findings by Hamilton Lane, nearly one-third of advisors are aiming to allocate 20% or more of their clients' portfolios to private markets in the near future. This shows a significant...

Continue Reading
Zack Kass: Driving AI Innovation at International Talent Conference

Updated Category News Views 165

Zack Kass: A Visionary Leader in AI Zack Kass, a prominent AI strategist and executive business advisor, is set to be the keynote speaker at the 2026 International Conference & Exposition organized by the Association for Talent Development. This global event, at the Los Angeles Convention Center, is expected to attract thousands of attendees aiming to explore the latest...

Continue Reading